-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ecwc/P9JOekRZtEV3oWPp/XhnRfnPsYb7Sa1jD21J4qdNHYGc8PEc0i9KI0rUFWm MgmKiuHVCXYmSQMk3pHPNQ== 0001144204-10-022332.txt : 20110127 0001144204-10-022332.hdr.sgml : 20110127 20100427134202 ACCESSION NUMBER: 0001144204-10-022332 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 CORRESP 1 filename1.htm Unassociated Document
April 27, 2010

VIA EDGAR

Securities and Exchange Commission
100 F Street N.E.
Washington, D.C.  20549

Attention:
Jim B. Rosenberg, Senior Assistant Chief Accountant
 
Mark Brunhofer, Senior Staff Accountant
 
Ibolya Ignat, Staff Accountant

Re:
Generex Biotechnology Corporation
 
Form 10-K for the Fiscal Year Ended July 31, 2009
 
Filed on October 14, 2009
 
File No. 000-25169

Ladies and Gentlemen:
 
On behalf of Generex Biotechnology Corporation (the “Company”), we are requesting additional time for the Company to submit its responses to the comments of the Commission staff as set forth in your letter, dated April 16, 2010, with respect to the Company’s Form 10-K as referenced above.  We respectfully request an extension until Friday, May 7, 2010 for the Company to submit its responses to your April 16th letter.  We have confirmed via telephone with Ms. Ignat that this extension is acceptable.
 
Please let me know if you have any questions.  You may contact me at telephone number (215) 851-8472, by facsimile (215) 851-8383 or by e-mail at gmiller@eckertseamans.com.
 
Thank you.
 
Very truly yours,
 
/s/ Gary A. Miller

Gary A. Miller

cc:
Rose C. Perri, Chief Financial Officer
 
Mark Fletcher, Executive Vice President & General Counsel

 
 
 

-----END PRIVACY-ENHANCED MESSAGE-----